Skip to content
  • info@BioLifeSolutions.com
  • 1.866.424.6543
  • Toggle search form
  • Toggle shopping cart 0

    Cart

  • Products
    • CryoStor®
      • CryoStor CS10
      • CryoStor CS5
      • CryoStor CS2
    • HypoThermosol®
      • HypoThermosol®
      • HypoThermosol for Hair
    • BloodStor®
      • BloodStor 100
      • BloodStor 55-5
      • BloodStor 27
    • Cell Thawing Media®
      • 10% Dextran 40 (IN 0.9% NaCl)
      • 10% Dextran 40 (IN 5% Dextrose)
    • All Products
  • Resources
    • Certificate of Analysis
    • Blog
    • Events
    • BioPreservation Today
    • White Papers
    • Press Releases
  • Evidence
    • Resource Links
  • Company
    • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Quality & Regulatory Systems
    • Distributors
    • Current Job Openings
  • Investors
    • Investors Home
    • Governance
    • Press Releases
    • Financials
    • Stock Information
    • Management Team
    • Investor Contact
  • Contact
    • General Inquiries
    • Master File Request
    • SDS Request Form
    • Sample Request
  • Ask the Scientists
  • ORDER
Close navigation
  • Primary Menu
BioLife Solutions

BioLife Solutions

Biopreservation Tools For Cells, Tissues, and Organs

Close search

Search

Search for:
Home/Blog/Tag: “CryoStor CS5”

Tag: CryoStor CS5

Human Mesenchymal Stem Cell Growth on Corning Denatured Collagen Dissolvable Microcarriers in a 5L Bioreactor 

Weber, Romeo, Dolley-Sonneville. Human Mesenchymal Stem Cell Growth on Corning Denatured Collagen Dissolvable Microcarriers in a 5L Bioreactor. Corning Incorporated, Life Sciences, Corning, NY USA

Regional Delivery of Chimeric Antigen Receptor– Engineered T Cells Effectively Targets HER2þ Breast Cancer Metastasis to the Brain

Princeman, Tilakawardane, Jeang, Aguilar, Murad, Park, Chang, Ostberg, Neman, Jandial, Portnow, Forman, Brown. Regional Delivery of Chimeric Antigen Receptor– Engineered T Cells Effectively Targets HER2þ Breast Cancer Metastasis to the Brain. Clin Cancer Res. 2017 Oct 23. doi: 10.1158/1078-0432.CCR-17-2041

A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis

Lim R, Hodge A, Moore G, Wallace E, Slevert W. A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis. Front. Pharmacol. 8:549.doi: 10.3389/fphar.2017.00549

Best Practices vs. Traditional Practices of Procedures and Technology for Preserving Viability and Functionality of T-Cells at Both -80 C and -190 C

Fink J, Abazari A, Hawkins B, Albert M, O’Donnell K, Mathew A. Best Practices vs. Traditional Practices of Procedures and Technology for Preserving Viability and Functionality of T-Cells at Both -80 C and -190 C. Biopreservation and Biobanking Volume 15, Number 3, 2017. DOI:10.1089=bio.2017.29021.abstracts

Transition to GMP, chemically-defined, xeno-free cryopreservation media increases post-thaw functionality of clinically relevant cell banks

Transition to GMP, chemically-defined, xeno-free cryopreservation media increases post-thaw functionality of clinically relevant cell banks

Cryopreservation and Transport of Jurkat T Cells Using Current and Optimized Practices: The Impact of Temperature and Length of Storage

Cryopreservation and Transport of Jurkat T Cells Using Current and Optimized Practices: The Impact of Temperature and Length of Storage    

Intent to treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults

Gardner R, Finney O, Annesley C, Brakke H, Summers C, Leger K, Bleakley M, Brown C, Mgebroff S, Spratt K, Hoglund V, Lindgren C, Oron A, Li D, Riddell S, Park J, Jensen M. Intent to treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults. Blood 2017 :blood-2017-02-769208. doi:…

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

Brown C, Alizadeh D, Starr R, Weng L, Wagner J, et al. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. N Engl J Med 2016;375:2561-9 DOI: 10.1056/NEJMoa1610497

Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques

Aliota M, Dudley D, Newman C, Mohr E, et al. Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques. PLoS Negl Trop Dis 10(12): e0005168 DOI:10.1371/journal.pntd.0005168

Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells

DiGiusto D, Canno P, Holmes M, Li L, et al. Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells. Molecular Therapy — Methods & Clinical Development 3, Article number: 16067 (2016) doi:10.1038/mtm.2016.67

Navigation

1 2 3 Next Page
Search for:

Blog Archives

Signup Area

Sign Up for Email Updates

Biolife Logo

  • Products
  • Company
  • Evidence
  • Investors
  • Blog
  • Ask the Scientists
  • Press Releases
  • Contact
© 2018 BioLifeSolutions Inc.  All Rights Reserved    |    Terms & Conditions    |    Privacy
  • twitter
  • linkedin
  • facebook